Table 3.

Summary of data collection

Participant typeData collection periodsPrimary recruitment strategiesEthical approval IDa
Victorian doctors who had provided VADApril to July 2020
  • Contacting medical practitioners who completed the mandatory training and provided consent to be contacted for future researchb

2000000033
Victorian and National regulatorscSeptember 2022 to July 2023
  • Drawing on professional networks

  • Directly contacting prospective participants via publicly available details

20000002700
Western Australian doctors who had provided VADMarch 2022 to May 2022
  • Drawing on professional networks

  • Directly contacting prospective participants via publicly available details

  • Advertising the study through social mediad

20000002700
Western Australian regulatorsJune 2022 to September 2022
  • Drawing on professional networks

  • Directly contacting prospective participants via publicly available detailsd

20000002700
Participant typeData collection periodsPrimary recruitment strategiesEthical approval IDa
Victorian doctors who had provided VADApril to July 2020
  • Contacting medical practitioners who completed the mandatory training and provided consent to be contacted for future researchb

2000000033
Victorian and National regulatorscSeptember 2022 to July 2023
  • Drawing on professional networks

  • Directly contacting prospective participants via publicly available details

20000002700
Western Australian doctors who had provided VADMarch 2022 to May 2022
  • Drawing on professional networks

  • Directly contacting prospective participants via publicly available details

  • Advertising the study through social mediad

20000002700
Western Australian regulatorsJune 2022 to September 2022
  • Drawing on professional networks

  • Directly contacting prospective participants via publicly available detailsd

20000002700

We note due to different periods of data collection and the progressive nature of this research project, we have previously published other work using some of this data. See Marcus Sellars and others, ‘Medical Practitioners’ Views and Experiences of Being Involved in Assisted Dying in Victoria, Australia: A Qualitative Interview Study among Participating Doctors’ (2022) 292 Soc Sci Med 114568; White and others (note 46); Lindy Willmott and others, ‘Participating Doctors’ Perspectives on the Regulation of Voluntary Assisted Dying in Victoria: A Qualitative Study’ (2021) 215 MJA 125; Haining, Willmott and White (note 25); Casey M Haining, Lindy Willmott and Ben P White, ‘Accessing Voluntary Assisted Dying in Regional Western Australia: Early Reflections from Key Stakeholders’ (2023) 23 RRH 8024 <https://www.rrh.org.au/journal/article/8024> accessed 6 April 2024.

a

This study was approved by the Queensland University of Technology Human Research Ethics Committee.

b

This process of seeking consent to contact about future research was sought through the mandatory training all doctors wishing to provide VAD must do. For more information on this sample, see Lindy Willmott and others, ‘Participating Doctors’ Perspectives on the Regulation of Voluntary Assisted Dying in Victoria: A Qualitative Study’ (2021) 215 MJA 125.

c

National regulators are used to describe regulators that operate nationally or across multiple states (and hence are not necessarily based in Victoria or WA, but may be), which have a role in regulating VAD.

d

For more details about recruitment method, see Haining, Willmott and White (note 25).

Table 3.

Summary of data collection

Participant typeData collection periodsPrimary recruitment strategiesEthical approval IDa
Victorian doctors who had provided VADApril to July 2020
  • Contacting medical practitioners who completed the mandatory training and provided consent to be contacted for future researchb

2000000033
Victorian and National regulatorscSeptember 2022 to July 2023
  • Drawing on professional networks

  • Directly contacting prospective participants via publicly available details

20000002700
Western Australian doctors who had provided VADMarch 2022 to May 2022
  • Drawing on professional networks

  • Directly contacting prospective participants via publicly available details

  • Advertising the study through social mediad

20000002700
Western Australian regulatorsJune 2022 to September 2022
  • Drawing on professional networks

  • Directly contacting prospective participants via publicly available detailsd

20000002700
Participant typeData collection periodsPrimary recruitment strategiesEthical approval IDa
Victorian doctors who had provided VADApril to July 2020
  • Contacting medical practitioners who completed the mandatory training and provided consent to be contacted for future researchb

2000000033
Victorian and National regulatorscSeptember 2022 to July 2023
  • Drawing on professional networks

  • Directly contacting prospective participants via publicly available details

20000002700
Western Australian doctors who had provided VADMarch 2022 to May 2022
  • Drawing on professional networks

  • Directly contacting prospective participants via publicly available details

  • Advertising the study through social mediad

20000002700
Western Australian regulatorsJune 2022 to September 2022
  • Drawing on professional networks

  • Directly contacting prospective participants via publicly available detailsd

20000002700

We note due to different periods of data collection and the progressive nature of this research project, we have previously published other work using some of this data. See Marcus Sellars and others, ‘Medical Practitioners’ Views and Experiences of Being Involved in Assisted Dying in Victoria, Australia: A Qualitative Interview Study among Participating Doctors’ (2022) 292 Soc Sci Med 114568; White and others (note 46); Lindy Willmott and others, ‘Participating Doctors’ Perspectives on the Regulation of Voluntary Assisted Dying in Victoria: A Qualitative Study’ (2021) 215 MJA 125; Haining, Willmott and White (note 25); Casey M Haining, Lindy Willmott and Ben P White, ‘Accessing Voluntary Assisted Dying in Regional Western Australia: Early Reflections from Key Stakeholders’ (2023) 23 RRH 8024 <https://www.rrh.org.au/journal/article/8024> accessed 6 April 2024.

a

This study was approved by the Queensland University of Technology Human Research Ethics Committee.

b

This process of seeking consent to contact about future research was sought through the mandatory training all doctors wishing to provide VAD must do. For more information on this sample, see Lindy Willmott and others, ‘Participating Doctors’ Perspectives on the Regulation of Voluntary Assisted Dying in Victoria: A Qualitative Study’ (2021) 215 MJA 125.

c

National regulators are used to describe regulators that operate nationally or across multiple states (and hence are not necessarily based in Victoria or WA, but may be), which have a role in regulating VAD.

d

For more details about recruitment method, see Haining, Willmott and White (note 25).

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close